SLC39A10 and acute myeloid leukemia: We found significantly higher expression of ZIP6 (Figure 2A; p = 0.0429), ZIP9 (Figure 2B; p = 0.0070) and ZIP10 (Figure 2C; p = 0.0171) in treatment‐naïve AML patients.